ECOR (electroCore, Inc. Common Stock)
Insider Trading Activity
Every open-market purchase and sale reported by ECOR officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-10 | Patricia Wilber | Director | A | — | — |
| 2026-09-10 | Thomas J. Errico | Director | A | — | — |
| 2026-09-10 | JOHN P GANDOLFO | Director | A | — | — |
| 2026-09-10 | James Charles Theofilos | Director | A | — | — |
| 2026-09-10 | Elena Bonfiglioli | Director | A | — | — |
| 2026-09-10 | Michael Fox | See Remarks | A | — | — |
| 2026-09-10 | Julie Ann Goldstein | Director | A | — | — |
| 2026-09-10 | Joshua S. Lev | See Remarks | A | — | — |
| 2026-08-25 | Joshua S. Lev | CFO and Interim President | MIXED | — | — |
| 2026-08-17 | Thomas J. Errico | Director | Buy | — | — |
| 2026-06-12 | Daniel S Goldberger | — | Sell | — | — |
| 2026-05-29 | Joshua S. Lev | CFO and Interim President | Sell | — | — |
| 2026-05-26 | Thomas J. Errico | Director | MIXED | — | — |
| 2026-05-22 | Joshua S. Lev | CFO and Interim President | Sell | — | — |
| 2026-04-14 | Daniel S Goldberger | — | Sell | — | — |
| 2026-04-14 | Michael Fox | Chief Operating Officer | A | — | — |
| 2026-04-01 | Joshua S. Lev | CFO and Interim President | A | — | — |
| 2026-03-20 | Thomas J. Errico | Director | X | — | — |
| 2026-01-28 | Joshua S. Lev | Chief Financial Officer | A | — | — |
| 2026-01-28 | Daniel S Goldberger | Chief Executive Officer | A | — | — |
| 2025-12-05 | Joshua S. Lev | Chief Financial Officer | Sell | — | — |
| 2025-12-03 | Daniel S Goldberger | Chief Executive Officer | Buy | — | — |
| 2025-11-14 | Joshua S. Lev | Chief Financial Officer | Sell | — | — |
| 2025-09-12 | Elena Bonfiglioli | Director | A | — | — |
| 2025-09-04 | Julie Ann Goldstein | Director | A | — | — |
| 2025-09-04 | JOHN P GANDOLFO | Director | A | — | — |
| 2025-09-04 | Thomas J. Errico | Director | A | — | — |
| 2025-09-04 | THOMAS M PATTON | Director | A | — | — |
| 2025-09-04 | Patricia Wilber | Director | A | — | — |
| 2025-08-13 | Thomas J. Errico | Director | Buy | — | — |
| 2025-08-12 | Daniel S Goldberger | Chief Executive Officer | Buy | — | — |
| 2025-08-05 | James Charles Theofilos | Director | A | — | — |
| 2025-05-27 | JOHN P GANDOLFO | Director | Buy | — | — |
| 2025-05-13 | Thomas J. Errico | Director | Buy | — | — |
| 2025-03-18 | Daniel S Goldberger | Chief Executive Officer | Buy | — | — |
| 2025-03-17 | Thomas J. Errico | Director | Buy | — | — |
| 2025-01-21 | Daniel S Goldberger | Chief Executive Officer | A | — | — |
| 2025-01-17 | Joshua S. Lev | Chief Financial Officer | A | — | — |
| 2024-09-05 | JOHN P GANDOLFO | Director | A | — | — |
| 2024-09-05 | Julie Ann Goldstein | Director | A | — | — |
| 2024-09-05 | Patricia Wilber | Director | A | — | — |
| 2024-09-05 | F PETER CUNEO | Director | A | — | — |
| 2024-09-05 | Thomas J. Errico | Director | A | — | — |
| 2024-09-05 | THOMAS M PATTON | Director | A | — | — |
| 2024-09-05 | Charles Steve Theofilos | Director | A | — | — |
| 2024-08-19 | Thomas J. Errico | Director | Buy | — | — |
| 2024-07-15 | F PETER CUNEO | Director | A | — | — |
| 2024-06-17 | JOHN P GANDOLFO | Director | Buy | — | — |
| 2024-06-07 | Thomas J. Errico | Director | A | — | — |
| 2024-06-07 | Charles Steve Theofilos | Director | Buy | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | Director | 454,992 | — |
| — | Director | 348,656 | — |
| — | 10%+ Owner | 223,292 | — |
| — | Chief Executive Officer | 211,471 | — |
| — | Director | 184,526 | — |
| — | Director | 129,277 | — |
| — | Director | 102,782 | — |
| — | Director | 101,387 | — |
| — | Director | 88,098 | — |
| — | CFO and Interim President | 84,889 | — |
| — | Director | 72,325 | — |
| — | Chief Operating Officer | 70,000 | — |
| — | Director | 67,592 | — |
| — | 10%+ Owner | 43,133 | — |
| — | Director | 30,549 | — |
| — | Chief Executive Officer | 24,582 | — |
| — | Director | 23,547 | — |
| — | Chief Financial Officer | 22,437 | — |
| — | Chief Medical Officer | 14,625 | — |
| — | Chief Financial Officer | 8,062 | — |
| — | Director | 5,665 | — |
| — | Director | 1,401 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the ECOR quote page; the site-wide leaderboard is on the insider transactions hub.